98 related articles for article (PubMed ID: 10667244)
1. Recombinant cytotoxins specific for cancer cells.
Debinski W
Ann N Y Acad Sci; 1999; 886():297-9. PubMed ID: 10667244
[No Abstract] [Full Text] [Related]
2. Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma.
Mintz A; Gibo DM; Madhankumar AB; Debinski W
J Neurooncol; 2003; 64(1-2):117-23. PubMed ID: 12952292
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
Hall WA; Vallera DA
Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
[TBL] [Abstract][Full Text] [Related]
4. Mutants of interleukin 13 with altered reactivity toward interleukin 13 receptors.
Thompson JP; Debinski W
J Biol Chem; 1999 Oct; 274(42):29944-50. PubMed ID: 10514477
[TBL] [Abstract][Full Text] [Related]
5. Novel anti-brain tumor cytotoxins specific for cancer cells.
Debinski W; Gibo DM; Obiri NI; Kealiher A; Puri RK
Nat Biotechnol; 1998 May; 16(5):449-53. PubMed ID: 9592393
[TBL] [Abstract][Full Text] [Related]
6. IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.
Mintz A; Gibo DM; Slagle-Webb B; Christensen ND; Debinski W
Neoplasia; 2002; 4(5):388-99. PubMed ID: 12192597
[TBL] [Abstract][Full Text] [Related]
7. Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells.
Han J; Yang L; Puri RK
J Neurooncol; 2005 Mar; 72(1):35-46. PubMed ID: 15803373
[TBL] [Abstract][Full Text] [Related]
8. Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas.
Debinski W; Gibo DM; Hulet SW; Connor JR; Gillespie GY
Clin Cancer Res; 1999 May; 5(5):985-90. PubMed ID: 10353730
[TBL] [Abstract][Full Text] [Related]
9. Molecular targeting of malignant gliomas with novel multiply-mutated interleukin 13-based cytotoxins.
Nash KT; Thompson JP; Debinski W
Crit Rev Oncol Hematol; 2001; 39(1-2):87-98. PubMed ID: 11418305
[TBL] [Abstract][Full Text] [Related]
10. Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model.
Kawakami K; Kawakami M; Kioi M; Husain SR; Puri RK
J Neurosurg; 2004 Dec; 101(6):1004-11. PubMed ID: 15597761
[TBL] [Abstract][Full Text] [Related]
11. Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types.
Vita N; Lefort S; Laurent P; Caput D; Ferrara P
J Biol Chem; 1995 Feb; 270(8):3512-7. PubMed ID: 7876085
[TBL] [Abstract][Full Text] [Related]
12. Novel way to increase targeting specificity to a human glioblastoma-associated receptor for interleukin 13.
Debinski W; Gibo DM; Puri RK
Int J Cancer; 1998 May; 76(4):547-51. PubMed ID: 9590132
[TBL] [Abstract][Full Text] [Related]
13. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
Kioi M; Kawakami K; Puri RK
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
[TBL] [Abstract][Full Text] [Related]
14. A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model.
Todhunter DA; Hall WA; Rustamzadeh E; Shu Y; Doumbia SO; Vallera DA
Protein Eng Des Sel; 2004 Feb; 17(2):157-64. PubMed ID: 15047912
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor.
Hilton DJ; Zhang JG; Metcalf D; Alexander WS; Nicola NA; Willson TA
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):497-501. PubMed ID: 8552669
[TBL] [Abstract][Full Text] [Related]
16. An immune regulatory cytokine receptor and glioblastoma multiforme: an unexpected link.
Debinski W
Crit Rev Oncog; 1998; 9(3-4):255-68. PubMed ID: 10201630
[TBL] [Abstract][Full Text] [Related]
17. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts.
Lutz RA; Feng N; Moser R
J Recept Signal Transduct Res; 1999; 19(1-4):181-90. PubMed ID: 10071757
[TBL] [Abstract][Full Text] [Related]
18. Expression of a functional IL-13Ralpha1 by rat B cells.
Pierrot C; Beniguel L; Bègue A; Khalife J
Biochem Biophys Res Commun; 2001 Oct; 287(4):969-76. PubMed ID: 11573960
[TBL] [Abstract][Full Text] [Related]
19. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
20. Reoxygenation of hypoxic glioblastoma multiforme cells potentiates the killing effect of an interleukin-13-based cytotoxin.
Liu TF; Cai J; Gibo DM; Debinski W
Clin Cancer Res; 2009 Jan; 15(1):160-8. PubMed ID: 19118043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
